Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study (PROGE)

Centre Francois Baclesse

Status: Completed

Conditions: Prostate Cancer Cured; Healthy Population Control

Treatments: Other: geriatric assessment

Study type: Interventional

Funder types: Other

Identifiers

NCT01797692

2011-A01256-35 (Other Identifier)

PROGE

Details and patient eligibility

About

This is a multicenter pilot study, proposed for cases and controls 3 departments in France.

Cases are cured patients who have had prostate cancer for at least 10 years. Cookies are healthy subjects selected by lottery on voter list.

Volunteer subjects (cases and controls) are offered a consultation and assessment with an geriatrician.

Full description

Volunteer subjects (cases and controls) are offered a consultation and assessment with an geriatrician.

During this consultation, ADL, IADL and MMS questionnary will be completed. neurocognitif testing will be done.

Enrollment: 74 estimated patients

Sex: Male

Ages: 75+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for patients:

• Patients aged 75 years or more
• Patients with a personal history of prostate cancer with a diagnosis ≥ 10 years
• Patients who received curative treatment (surgery, radiotherapy,hormone therapy, brachytherapy, technical ablative) for localized prostate cancer
• Patients considered cured of prostate cancer (regardless of initial treatment)
• Patients with previously agreed to participate in a case-control study in the general population (study QALIPRO) as a case and volunteer to receive an assessment of geriatric
• Signature of consent
• Affiliation to a social security system

Exclusion Criteria for patients:

• Patients under 75 years
• Patients with recurrent or metastatic
• Persons deprived of liberty or under guardianship

Inclusion Criteria for control population:

• Male subjects
• Subjects of 75 years or more
• Subjects that do not have cancer or a history of cancer (except basal cell skin cancer)
• Subject has previously agreed to participate in a case-control study in the general population (study QALIPRO) as a voluntary witness and to benefit from a balance oncogeriatrics
• Subjects who gave their written consent to participate in the study

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

74 participants in 1 patient group

geriatric assessment

Other group

Description:

geriatric assessment

Treatment:

Other: geriatric assessment